Kamagra enthält Sildenafilcitrat als pharmakologisch aktiven Bestandteil. Dieser hemmt selektiv die Phosphodiesterase-5 und erhöht dadurch die Konzentration von cGMP im Corpus cavernosum. Der Effekt ist zeitlich begrenzt, da die Halbwertszeit von Sildenafil etwa vier Stunden beträgt. In der galenischen Form als Mundgel erfolgt die Resorption besonders rasch, was zu einem schnelleren Wirkeintritt führt. Der Abbau erfolgt überwiegend hepatisch über CYP3A4, wobei ein aktiver Metabolit entsteht, der zur Gesamtwirkung beiträgt. Typische Nebenwirkungen ergeben sich aus der Vasodilatation, darunter leichte Kopfschmerzen und nasale Kongestion. In klinischen Beschreibungen wird kamagra oral jelly im Zusammenhang mit der schnelleren Absorption erwähnt.
Microsoft word - registration form-revised.doc
MID-COUNTY ENDODONTIC GROUP, P.A. 60 W. RIDGEWOOD AVE. RIDGEWOOD NJ07450201.652.3311 250 KINDERKAMACK RD. WESTWOOD NJ07675201.666.4546 PATIENT REGISTRATION
Date:_________________ Patient’s Name:_________________________________________________________________ Title: ___________
Parent’s name (if patient is a minor):_______________________________________
Date of Birth: __________________ SS# ____________________________ Marital status: ____________ Sex: ______
Home Address:_________________________________________City__________________State_______Zip_________
Home Phone: __________________________________ Cellular Phone: ____________________________________
Employer : ________________________________________________ Work Phone: ____________________________
Person responsible for account:_______________________________
General Dentist:_______________________________________ Referred by:_______________________________
Have you been a patient with us before? _________
MEDICAL HISTORY
Are you currently under the care of a physician? □Yes □No For what condition? ____________________________
If yes, name and phone # of your physician:________________________________________________________________
Do you take an aspirin a day? □Yes □No Do you take coumadin? □Yes □No Are you currently taking or have you previously taken Bisphosphonate medications such as:
Fosamax, Actonel or Zometa within the past 12 months? □Yes □No
Are you currently taking immune suppressive medications such as Corticosteroids?
Have you had or do you currently have? Please circle ٭Congenital heart defects
٭Radiation therapy to Head/Neck w/in 12 months Seizures
*You must be pre-medicated with antibiotic prior to your dental appointment. For consultations, no need for pre-medication.
Please list all medications you are currently taking: _________________________________________________________________________________________________ _________________________________________________________________________________________________ _________________________________________________________________________________________________
Have you had any allergic reactions to the following? Please circle
Do you have any history of substance abuse? □Yes
Is there any other medical/dental condition the treating doctor should know?
If yes, please explain: ___________________________________________________________________________________
I certify that the information on these pages are correct and accurate. I also certify that I am the patient (or authorized agent of the patient) authorized to furnish all information requested.
Patient / (or Guardian) Signature: _______________________________________________________ Dental Insurance Information
Insurance company name and address: __________________________________________________________________
Subscriber’s name : _________________________________ SS# ________________________ DOB:________________
Subscriber address: __________________________________________________________________________________
Subscriber’s employer name and address:
Group or Policy # : ___________________________________
Secondary insurance company name and address: _________________________________________________________
Subscriber’s name : _________________________________ SS# ________________________ DOB:________________
Subscriber’s employer name and address:
Group or Policy # : ___________________________________
RETURN VISIT UPDATE
(For patients who have not been seen at our office for over a year)
Have there been any changes in your medical history since your last visit? □Yes
Comments ________________________________________________________________________________________ _________________________________________________________________________________________________ Signature: _____________________________________________
Panel of Influenza A Viruses for Assessment of Resistance to Neuraminidase Inhibitors Panel Description: This panel of influenza A viruses is for the evaluation of resistance to neuraminidase(NA) inhibitors and for the standardization of IC50 values. The package includes fourhuman influenza A viruses isolated, plaque purified and cultured in Madin Darby caninekidney (MDCK) cells. There are t
Originalpublikationen Augenklinik im Jahr 2006 1. Barthelmes D., Sutter F.K., Kurz-Levin M., Bösch M., Helbig H., Niemeyer G., Fleischhauer J.C. : Quantitative analysis of OCT characteristics in patients with achromatopsia and blue cone monochromatism Invest Ophthalmol Vis Sci 2006;47:1161-1166 2. Bemelmans A.P., Kostic C., Crippa S.V., Hauswirth W.H., Lem J., Seeliger M.W., Wenz